We’ve published a few “graphs” illustrating topics interesting to us.  Last month published a graph showing Celgene’s biomarker and trial activities.  More recently we published a biomarker and trial landscape graph for Alzheimer’s disease. Because Alzheimer’s is getting a lot of attention at the BIO Convention we wanted to follow up with a graph outlining the biopharma players in Alzhiemer’s.  The graph shows the trial activity, the related biomarkers and the biopharma companies sponsoring those trials.